Dacetuzumab

Definition 1

A humanized monoclonal antibody directed against the CD40 receptor with potential antineoplastic activity. Dacetuzumab specifically binds to and inhibits the CD40 receptor, thereby inducing apoptosis and inhibiting cellular proliferation via antibody-dependent cellular cytotoxicity (ADCC) in cells that overexpress this receptor. The CD40 receptor, a member of the tumor necrosis factor (TNF) receptor super-family, is highly expressed on most B lineage hematologic malignancies including multiple myeloma, non-Hodgkin's lymphoma, chronic lymphocytic leukemia, Hodgkin's disease and acute lymphoblastic leukemia. (NCI Thesaurus)

Definition 2

A monoclonal antibody that binds to cells that have the CD40 antigen on their surface, including cells from multiple myeloma, non-Hodgkin lymphoma, and chronic lymphocytic leukemia. SGN-40 is being studied in the treatment of cancer. It is a type of monoclonal antibody. (NCI Dictionary)

YOU MAY ALSO LIKE

Dacarbazine

A drug that is used to treat Hodgkin lymphoma and malignant melanoma and is being studied in the treatment of other types…

DACA

A substance being studied in the treatment of cancer. It is a type of topoisomerase inhibitor. Also called acridine carboxamide.

Dabska tumor

A rare, slow-growing tumor of blood vessels that forms in or under the skin anywhere on the body. Dabska tumors may appear…

Dabrafenib

A drug used alone or with trametinib to treat melanoma that cannot be removed by surgery or has spread to other…

DAB389 Epidermal Growth Factor

A recombinant fusion protein composed of the diphtheria toxin with the receptor-binding domain replaced by human epidermal growth factor (EGF). When…

DAB2IP wt Allele

Human DAB2IP wild-type allele is located within 9q33.1-q33.3 and is approximately 218 kb in length. This allele, which encodes disabled homolog 2-interacting…